Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Ovarian Neoplasms and ERCC2[original query] |
---|
Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 Feb 15 (2): 306-11. Huang Wen-Yi, Berndt Sonja I, Kang Daehee, Chatterjee Nilanjan, Chanock Stephen J, Yeager Meredith, Welch Robert, Bresalier Robert S, Weissfeld Joel L, Hayes Richard |
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Oct 25 (29): 4528-35. Marsh Sharon, Paul Jim, King Cristi R, Gifford Gillian, McLeod Howard L, Brown Robe |
DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Molecular cancer 2008 7 (1): 36. Bernard-Gallon Dominique, Bosviel Rémy, Delort Laetitia, Fontana Luc, Chamoux Alain, Rabiau Nadège, Kwiatkowski Fabrice, Chalabi Nasséra, Satih Samir, Bignon Yves-Je |
Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecologic oncology 2009 May 113 (2): 264-9. Kim Hee Seung, Kim Mi-Kyung, Chung Hyun Hoon, Kim Jae Weon, Park Noh Hyun, Song Yong Sang, Kang Soon Be |
Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer. Cancer 2012 Feb 118 (3): 689-97. Fleming Nicole D, Agadjanian Hasmik, Nassanian Hoorig, Miller Carl W, Orsulic Sandra, Karlan Beth Y, Walsh Christine |
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
[Association of polymorphisms in glutathione-S-transferase and DNA repair genes with ovarian cancer risk in the Russian population]. Genetika 2012 Jul 48 (7): 901-4. Khokhrin D V, Khrunin A V, Moiseev A A, Gorbunov V A, Limborskaia S |
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility. Molecular biology reports 2013 Jan . Mohamed FZ, Hussien YM, Albakry MM, Mohamed RH, Said NM |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
Identification and Functional Testing of ERCC2 Mutations in a Multi-national Cohort of Patients with Familial Breast- and Ovarian Cancer. PLoS genetics 2016 Aug 12 (8): e1006248. Rump Andreas, Benet-Pages Anna, Schubert Steffen, Kuhlmann Jan Dominik, Janavi?ius Ram?nas, Machá?ková Eva, Foretová Lenka, Kleibl Zdenek, Lhota Filip, Zemankova Petra, Betcheva-Krajcir Elitza, Mackenroth Luisa, Hackmann Karl, Lehmann Janin, Nissen Anke, DiDonato Nataliya, Opitz Romy, Thiele Holger, Kast Karin, Wimberger Pauline, Holinski-Feder Elke, Emmert Steffen, Schröck Evelin, Klink Barba |
Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer. European journal of obstetrics, gynecology, and reproductive biology 2017 Jan 208 36-40. Romanowicz Hanna, Michalska Magdalena M, Samulak Dariusz, Malinowski Jakub, Szaflik Tomasz, Bie?kiewicz Jan, Smolarz Bea |
Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer. Oncotarget 2016 Nov . Zhang Wei, Zhang Zhif |
Association between ERCC2 rs13181 polymorphism and ovarian cancer risk: an updated meta-analysis with 4024 subjects. Archives of gynecology and obstetrics 2017 Jul . Li JieNa, Pan Lei, Qin Xia, Chu HongYan, Mu HuiYing, Wan GuoXi |
Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis. Cancer treatment reviews 2017 Dec 61 35-52. Assis Joana, Pereira Carina, Nogueira Augusto, Pereira Deolinda, Carreira Rafael, Medeiros R |
The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility. Bioscience reports 2018 Apr . Zhao Zhiguang, Zhang Anqi, Zhao Yuan, Xiang Junmiao, Yu Danyang, Liang Zongwen, Xu Chaoyi, Zhang Qiong, Li Jianmin, Duan Pi |
Exome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genes. Frontiers in oncology 2021 11 649435. Doddato Gabriella, Valentino Floriana, Giliberti Annarita, Papa Filomena Tiziana, Tita Rossella, Bruno Lucia Pia, Resciniti Sara, Fallerini Chiara, Benetti Elisa, Palmieri Maria, Mencarelli Maria Antonietta, Fabbiani Alessandra, Bruttini Mirella, Orrico Alfredo, Baldassarri Margherita, Fava Francesca, Lopergolo Diego, Lo Rizzo Caterina, Lamacchia Vittoria, Mannucci Sara, Pinto Anna Maria, Curr Aurora, Mancini Virginia, , , Mari Francesca, Renieri Alessandra, Ariani Frances |
Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients. Bulletin of experimental biology and medicine 2021 Oct . Zavarikina T M, Khokhlova S V, Tyulyandina A S, Khabas G N, Asaturova A V, Nosova Yu V, Brenner P K, Kapralova M A, Khodirev D S, Stenina M |
Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology, research and practice 2024 1 254 155075. Seref Bugra Tuncer, Betul Celik, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Busra Kurt Gültaslar, Demet Akdeniz Odemis, Mukaddes Avsar, Fatma Sen, P?nar Mualla Saip, Hulya Yazi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: